Osaic Holdings’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49 | Sell |
35
-105
| -75% | -$147 | ﹤0.01% | 7126 |
|
|
2025
Q1 | $248 | Buy |
+140
| New | +$248 | ﹤0.01% | 6963 |
|
|
2023
Q1 | – | Sell |
-3,656
| Closed | -$9K | – | 7420 |
|
|
2022
Q4 | $9K | Buy |
3,656
+333
| +10% | +$820 | ﹤0.01% | 5993 |
|
|
2022
Q3 | $14K | Buy |
3,323
+1,213
| +57% | +$5.11K | ﹤0.01% | 5823 |
|
|
2022
Q2 | $11K | Buy |
2,110
+80
| +4% | +$417 | ﹤0.01% | 6019 |
|
|
2022
Q1 | $21K | Buy |
2,030
+80
| +4% | +$828 | ﹤0.01% | 5648 |
|
|
2021
Q4 | $22K | Buy |
1,950
+1,119
| +135% | +$12.6K | ﹤0.01% | 5712 |
|
|
2021
Q3 | $17K | Buy |
831
+314
| +61% | +$6.42K | ﹤0.01% | 5882 |
|
|
2021
Q2 | $13K | Buy |
517
+253
| +96% | +$6.36K | ﹤0.01% | 5902 |
|
|
2021
Q1 | $8K | Buy |
264
+153
| +138% | +$4.64K | ﹤0.01% | 5953 |
|
|
2020
Q4 | $2K | Buy |
+111
| New | +$2K | ﹤0.01% | 6029 |
|